文献速递神经MR

联合定量磁敏感成像、动脉自旋标记与弥散加权成像鉴别高级别胶质瘤真性进展与假性进展

Combining quantitative susceptibility mapping, arterial spin labeling and diffusion weighted imaging for distinguishing true progression from pseudoprogression in high-grade gliomas.
PubMed 文献 · Neuroradiology · 2025-10-10

本研究纳入49例术后新发强化灶的高级别胶质瘤患者,评估QSM、3D-pCASL和DWI鉴别真性进展与假性进展的诊断效能。真性进展组出血灶面积占比(proQSM)显著低于假性进展组(p<0.001),相对最大脑血流量(rCBFmax)显著高于假性进展组(p<0.001),两者AUC分别为0.891和0.881,联合后AUC提升至0.948。

要点

  • 真性进展proQSM显著低于假性进展(p<0.001),AUC为0.891。
  • 真性进展rCBFmax显著高于假性进展(p<0.001),AUC为0.881。
  • proQSM联合rCBFmax可将AUC提升至0.948。

核心结论

  • proQSM和rCBFmax可作为鉴别真性进展与假性进展的互补生物标志物。
  • QSM与ASL联合较常规参数显著提高诊断准确率,为术后高级别胶质瘤监测提供无创策略。

研究设计与样本

  • 研究纳入49例术后高级别胶质瘤伴新发强化灶患者,均行常规MRI、QSM、3D-pCASL和DWI检查。
  • 最终诊断经6个月纵向MRI随访或再手术组织病理学确认。
  • 采用独立样本t检验比较真性进展与假性进展组的定量参数,并以ROC曲线分析评估诊断效能。

关键影像表现/征象

  • 真性进展病灶的出血灶面积占比(proQSM)显著低于假性进展(p<0.001)。
  • 真性进展病灶的相对最大脑血流量(rCBFmax)显著高于假性进展(p<0.001)。
  • 真性进展病灶的相对最小表观弥散系数(rADCmin)轻度降低(p<0.05),磁敏感值(SUS)组间无差异(p=0.164)。

诊断标准与关键数值

  • proQSM鉴别真性进展与假性进展的AUC为0.891。
  • rCBFmax鉴别真性进展与假性进展的AUC为0.881。
  • proQSM联合rCBFmax的AUC为0.948。

临床应用与阅片要点

  • 术后高级别胶质瘤新发强化灶鉴别时,可结合QSM测量的proQSM与ASL测量的rCBFmax进行综合判断。
  • proQSM与rADCmin均与rCBFmax呈负相关(p<0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: This study aimed to evaluate and compare the diagnostic performance of quantitative susceptibility mapping (QSM), 3D pseudo-continuous arterial spin labeling (3D-pCASL), and diffusion-weighted imaging (DWI) in differentiating true progression (TP) from pseudoprogression (PsP) in postoperative high-grade glioma (HGG) patients.

METHODS: Forty-nine postoperative HGG patients with newly enhanced lesions were enrolled. All participants underwent conventional MRI, QSM, 3D-pCASL, and DWI. Final diagnoses were confirmed by 6-month longitudinal MRI follow-up or histopathology from reoperation. Quantitative parameters-including the hemorrhagic foci area proportion (proQSM), magnetic susceptibility (SUS), relative maximum cerebral blood flow (rCBFmax), and relative minimum apparent diffusion coefficient (rADCmin)-were compared between TP and PsP groups using independent samples t-tests. Diagnostic efficacy was assessed via receiver operating characteristic (ROC) curve analysis, and interparametric correlations were evaluated.

RESULTS: TP lesions exhibited significantly lower proQSM (p < 0.001) and higher rCBFmax (p < 0.001) than PsP, with area under the curve (AUC) values of 0.891 and 0.881, respectively. While rADCmin was marginally reduced in TP (p < 0.05), SUS showed no intergroup difference (p = 0.164). Combining proQSM with rCBFmax significantly improved diagnostic accuracy (AUC = 0.948). Furthermore, proQSM, rADCmin showed a negative correlation with rCBFmax, respectively. (p < 0.0001).

CONCLUSION: proQSM and rCBFmax serve as complementary biomarkers for TP and PsP differentiation. The integration of QSM and ASL imaging significantly improves diagnostic accuracy compared to conventional parameters, providing a noninvasive strategy for postoperative HGG surveillance.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Diao Y, Liang H, Lei F, et al. Combining quantitative susceptibility mapping, arterial spin labeling and diffusion weighted imaging for distinguishing true progression from pseudoprogression in high-grade gliomas. Neuroradiology. 2025. PMID: 41071245. doi:10.1007/s00234-025-03797-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。